Accelerating Innovation (AI) for Kids with Cancer Act
- Bill Number
- H.R. 9632
- Origin Chamber
- House
- Congress
- 119th Congress, Session 2
- Status
- Introduced
- Latest Action
- 2026-07-09: Referred to the House Committee on Energy and Commerce.
- Last Updated
- 2026-07-10T10:23:21Z
AI-Generated Summary
Purpose This legislation aims to coordinate federal efforts using advanced technologies, such as artificial intelligence (AI), to enhance diagnoses, treatments, cures, and prevention for pediatric cancer.
Key Provisions
- The President, in consultation with the Secretary of Health and Human Services, must appoint a Coordinator of AI Innovation to lead these efforts; this coordinator serves on the Domestic Policy Council.
- The coordinator must identify ways to speed AI-driven work at the Childhood Cancer Data Initiative (CCDI), including better clinical trial design, shared data platforms, improved data infrastructure, AI-enhanced analysis for predictions and biomarkers, and use of multimodal data.
- The Secretary must integrate AI into existing interoperability efforts for electronic health records and claims data, while ensuring patients or their representatives control their information.
- The Secretary must finalize interoperability standards for AI use with patient data that handle both structured and unstructured information and support safe, privacy-compliant exchanges.
- The Secretary must submit a report to designated congressional committees within 180 days of enactment.
- The bill authorizes necessary funding for fiscal years 2027 through 2031, plus an additional $100,000,000 per year specifically for CCDI activities.
Significant Changes to Existing Law The bill creates a new federal coordinator role focused on AI for pediatric cancer and adds targeted funding and mandates for AI integration into the existing Childhood Cancer Data Initiative. It requires specific standards development for AI-compatible health data interoperability, which expands current federal work on health information exchange.
Potential Impacts
- Government agencies: Increases coordination responsibilities within the executive branch and directs additional resources to the Department of Health and Human Services and related programs.
- Citizens: Aims to improve outcomes for children with cancer through faster adoption of AI tools in research and care.
- International relations: No direct provisions, though enhanced U.S. AI capabilities in health research could indirectly affect global scientific collaboration.
Main Stakeholders Affected
- Federal agencies involved in health research and data policy.
- Pediatric cancer patients, families, and their authorized representatives.
- Researchers, academic institutions, and private-sector entities working with CCDI data.
- Congressional committees overseeing health, commerce, and science policy.
Notable Legal, Constitutional, or Political Implications The legislation emphasizes patient control over health data and privacy-compliant standards, aligning with existing federal privacy protections. It operates within Congress’s authority to authorize appropriations and direct executive coordination on health matters. No major constitutional issues are raised in the text.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Rep. McCaul, Michael T. [R-TX-10]
Cosponsors (2)
Rep. Bera, Ami [D-CA-6], Rep. Kelly, Mike [R-PA-16]
Recent Actions
- 2026-07-09: Referred to the House Committee on Energy and Commerce.
- 2026-07-09: Introduced in House
- 2026-07-09: Introduced in House
Bill Versions
- Accelerating Innovation (AI) for Kids with Cancer Act — issued 2026-07-09 — PDF (5 pages)